Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2014-11-21

Two new medicines recommended for the treatment of chronic hepatitis C

View source ↗

Summary

The EMA recommended two new medicines for the treatment of chronic hepatitis C, advancing options for patients with this condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Not specified